vs

Side-by-side financial comparison of Four Corners Property Trust, Inc. (FCPT) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

Four Corners Property Trust, Inc. is the larger business by last-quarter revenue ($78.2M vs $75.5M, roughly 1.0× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 9.4%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 8.4%).

Four Corners Property Trust, Inc. is a publicly traded real estate investment trust that acquires, owns, and manages a portfolio of high-quality net-leased commercial properties. Its assets are primarily restaurant and retail locations across the United States, with tenants largely operating in stable consumer-facing industry segments with proven operational performance.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

FCPT vs PBYI — Head-to-Head

Bigger by revenue
FCPT
FCPT
1.0× larger
FCPT
$78.2M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+18.4% gap
PBYI
27.7%
9.4%
FCPT
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
8.4%
FCPT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FCPT
FCPT
PBYI
PBYI
Revenue
$78.2M
$75.5M
Net Profit
$30.4M
Gross Margin
69.3%
Operating Margin
55.3%
22.7%
Net Margin
38.8%
Revenue YoY
9.4%
27.7%
Net Profit YoY
16.0%
EPS (diluted)
$0.28
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FCPT
FCPT
PBYI
PBYI
Q1 26
$78.2M
Q4 25
$75.7M
$75.5M
Q3 25
$74.1M
$54.5M
Q2 25
$72.8M
$52.4M
Q1 25
$71.5M
$46.0M
Q4 24
$68.3M
$59.1M
Q3 24
$66.8M
$80.5M
Q2 24
$66.5M
$47.1M
Net Profit
FCPT
FCPT
PBYI
PBYI
Q1 26
$30.4M
Q4 25
$29.4M
Q3 25
$28.8M
$8.8M
Q2 25
$27.9M
$5.9M
Q1 25
$26.2M
$3.0M
Q4 24
$26.2M
Q3 24
$25.6M
$20.3M
Q2 24
$24.7M
$-4.5M
Gross Margin
FCPT
FCPT
PBYI
PBYI
Q1 26
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Operating Margin
FCPT
FCPT
PBYI
PBYI
Q1 26
55.3%
Q4 25
22.7%
Q3 25
17.6%
Q2 25
12.7%
Q1 25
8.7%
Q4 24
22.6%
Q3 24
27.4%
Q2 24
-4.6%
Net Margin
FCPT
FCPT
PBYI
PBYI
Q1 26
38.8%
Q4 25
38.9%
Q3 25
38.9%
16.2%
Q2 25
38.3%
11.2%
Q1 25
36.6%
6.5%
Q4 24
38.3%
Q3 24
38.3%
25.2%
Q2 24
37.1%
-9.6%
EPS (diluted)
FCPT
FCPT
PBYI
PBYI
Q1 26
$0.28
Q4 25
$0.27
$0.26
Q3 25
$0.28
$0.17
Q2 25
$0.28
$0.12
Q1 25
$0.26
$0.06
Q4 24
$0.27
$0.40
Q3 24
$0.27
$0.41
Q2 24
$0.27
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FCPT
FCPT
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$29.6M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$1.7B
$130.3M
Total Assets
$3.0B
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FCPT
FCPT
PBYI
PBYI
Q1 26
$29.6M
Q4 25
$12.1M
$97.5M
Q3 25
$6.7M
$94.4M
Q2 25
$6.0M
$96.0M
Q1 25
$22.3M
$93.2M
Q4 24
$4.1M
$101.0M
Q3 24
$44.5M
$96.7M
Q2 24
$17.2M
$96.8M
Total Debt
FCPT
FCPT
PBYI
PBYI
Q1 26
Q4 25
$1.2B
$22.7M
Q3 25
$1.2B
$34.0M
Q2 25
$1.2B
$45.3M
Q1 25
$1.2B
$56.7M
Q4 24
$1.1B
$68.0M
Q3 24
$1.1B
$79.3M
Q2 24
$1.2B
$90.7M
Stockholders' Equity
FCPT
FCPT
PBYI
PBYI
Q1 26
$1.7B
Q4 25
$1.6B
$130.3M
Q3 25
$1.5B
$115.3M
Q2 25
$1.5B
$104.7M
Q1 25
$1.4B
$97.1M
Q4 24
$1.5B
$92.1M
Q3 24
$1.4B
$71.1M
Q2 24
$1.3B
$48.5M
Total Assets
FCPT
FCPT
PBYI
PBYI
Q1 26
$3.0B
Q4 25
$2.9B
$216.3M
Q3 25
$2.8B
$202.9M
Q2 25
$2.8B
$194.9M
Q1 25
$2.7B
$196.2M
Q4 24
$2.7B
$213.3M
Q3 24
$2.6B
$220.7M
Q2 24
$2.5B
$205.0M
Debt / Equity
FCPT
FCPT
PBYI
PBYI
Q1 26
Q4 25
0.74×
0.17×
Q3 25
0.79×
0.30×
Q2 25
0.81×
0.43×
Q1 25
0.84×
0.58×
Q4 24
0.78×
0.74×
Q3 24
0.84×
1.12×
Q2 24
0.92×
1.87×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FCPT
FCPT
PBYI
PBYI
Operating Cash FlowLast quarter
$14.4M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FCPT
FCPT
PBYI
PBYI
Q1 26
Q4 25
$192.3M
$14.4M
Q3 25
$48.9M
$9.7M
Q2 25
$43.8M
$14.1M
Q1 25
$51.6M
$3.6M
Q4 24
$144.1M
$15.6M
Q3 24
$43.4M
$11.0M
Q2 24
$39.7M
$1.0M
Free Cash Flow
FCPT
FCPT
PBYI
PBYI
Q1 26
Q4 25
$14.4M
Q3 25
$9.7M
Q2 25
$14.1M
Q1 25
$3.6M
Q4 24
$15.6M
Q3 24
$11.0M
Q2 24
$1.0M
FCF Margin
FCPT
FCPT
PBYI
PBYI
Q1 26
Q4 25
19.1%
Q3 25
17.7%
Q2 25
26.8%
Q1 25
7.7%
Q4 24
26.4%
Q3 24
13.7%
Q2 24
2.1%
Capex Intensity
FCPT
FCPT
PBYI
PBYI
Q1 26
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Cash Conversion
FCPT
FCPT
PBYI
PBYI
Q1 26
Q4 25
6.53×
Q3 25
1.70×
1.10×
Q2 25
1.57×
2.41×
Q1 25
1.97×
1.21×
Q4 24
5.51×
Q3 24
1.70×
0.54×
Q2 24
1.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FCPT
FCPT

Rental revenue$69.8M89%
Restaurant revenue$8.4M11%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons